logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9643946 B1

PDFFull Text
Date of Patent:
May. 09, 2017

Filed:

Feb. 28, 2014

Tricyclic compound and use thereof

Applicant:

SK Chemicals Co., Ltd., Seongnam-si, Gyeonggi-do, KR;

Inventors:

Ju Young Lee, Suwon-si, KR;

Jeong A Lee, Ansan-si, KR;

Jaeseung Ahn, Seoul, KR;

Je Ho Ryu, Seongnam-si, KR;

Min-Young Han, Seongnam-si, KR;

Taekyung Yoo, Uiwang-si, KR;

Joon Ho Sa, Seongnam-si, KR;

Jae-Sun Kim, Suwon-si, KR;

Jeongmin Seo, Seongnam-si, KR;

Assignee:

SK CHEMICALS CO., LTD., Seongnam-si, KR;

Attorney:

Sughrue Mion, PLLC

Primary Examiner:

Wu-Cheng Winston Shen

Assistant Examiner:

Christopher R Stone

Int. Cl.
CPC ...
C07D 307/80 (2006.01); C07D 313/10 (2006.01); C07D 335/02 (2006.01); C07D 405/12 (2006.01); C07D 239/70 (2006.01); C07D 307/20 (2006.01); C07C 317/18 (2006.01); C07C 229/46 (2006.01); C07C 59/72 (2006.01); C07D 223/20 (2006.01); C07D 311/80 (2006.01); C07D 313/12 (2006.01); C07D 407/12 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 307/80 (2013.01); C07C 59/72 (2013.01); C07C 229/46 (2013.01); C07C 317/18 (2013.01); C07D 223/20 (2013.01); C07D 239/70 (2013.01); C07D 307/20 (2013.01); C07D 311/80 (2013.01); C07D 313/10 (2013.01); C07D 313/12 (2013.01); C07D 335/02 (2013.01); C07D 405/12 (2013.01); C07D 407/12 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07C 2101/02 (2013.01); C07C 2103/26 (2013.01); C07C 2103/32 (2013.01);
Abstract

The present invention relates to: a compound selected from the group consisting of a tricyclic compound having the structure of formula I, a pharmaceutically acceptable salt, an isomer, a solvate and a precursor thereof; and a use thereof. The compound effectively controls GPR40, and thus, can be effectively used for the prophylaxis or treatment of diseases associated with GPR40, for example, diabetes and many other diseases.

Find Patent Forward Citations

Loading…